Testimonials

Hear What Previous Attendees Have to Say

 

This was a great conference for staying on top of some of the latest developments in IO models and getting a better understanding of the various models, their utility and limitations.  The size of the conference allows for many fruitful discussions and ease of meeting with several of the major CROs that provide models for those in the immuno-oncology space.

Michael Mattie, Associate Director, Translational Medicine Kite Pharma

PREDiCT Series Attendee

 

This conference is designed so well that I always find answers to many of my questions and leave the conference with finding at least one collaborator or vendor to work with.

Shiva Kazerounian, Principal Scientist, In vivo Pharmacology Lead, Berg health

PREDiCT Series Attendee

 

Thank you for putting on an excellent and thought provoking conference   I found this an extremely enjoyable meeting and appreciated the diversity of approaches used by the different speakers to address their specific needs. There is no one-size-fits-all preclinical model to test human I/O molecules, however between the options on the table there are hopefully one or two good fits.

Graham Thomas, Principal Scientist, COI Pharmaceuticals

PREDiCT Series Attendee

 

The Predict: Tumor Models is always an excellent mix of researchers at the forefront of academia and industry in an approachable format.

Joshua Breunig, Professor, Cedars Sinai/UCLA

PREDiCT Series Attendee

 

This was a great scientific meeting and networking opportunity. It brought together key players in the field to discuss important strategic issues of mutual interest.

Brian R. Berridge, Head, WW Animal Research Strategy, GSK

PREDiCT Series Attendee

 

This was a great opportunity to network and meet new people in the industry, while learning opportunities for collaboration, therapy successes and model failures that are being experienced in the IO field. Very informative.

Sasha Farina, Senior Research Associate, Pulse Biosciences

PREDiCT Series Attendee

 

Great group of researchers, great talks and an excellent focus on model generation and rationale. I learned an amazing amount about setting up in vivo models for IO studies to enable development of next generation oncology treatments.

Daniel Clemens, Scientist II, Verseon Corporation

PREDiCT Series Attendee

 

Great conference! No complaints, only compliments. A valuable symposium that helps better understand the latest advances in the field.

Vladi Juric, Research Scientist, Gilead

PREDiCT Series Attendee

 

It's not just about CRO marketing seminars.  This is a really nice small boutique conference focused on the most recent breakthroughs on the mechanistics of tumor models and ex vivo models.  Positively surprised of the quality of conference.

Betty Chang, Angarus

PREDiCT Series Attendee

 

The depth of the discussion, and opportunities to hear perspectives from those leading the industry on developing models made this an exceptionally valuable meeting - I look forward to participating in future sessions.

Barbara Joyce-Shaikh, Merck

PREDiCT Series Attendee

 

The meeting was excellent. I was impressed with the array of highly relevant experts that were brought together to speak.

Andreas Baudy, Associate Principal Scientist, Merck

PREDiCT Series Attendee

 

I thought the conference was very focused. It was time well spent. I learned a lot and had productive networking sessions.

Hicham Alaoui, Director, Biochemical & Cellular Pharmacology, Genentech

PREDiCT Series Attendee

 

A fantastic platform for industry and academics to come together and discuss how this field should and will move forward.

Moody Suliman, Nortis

PREDiCT Series Attendee

 

A great forum for discussion and networking that is hard to find in larger conferences. Good to meet knowledgeable delegates ready to take action in their focus area.

Gwen Fewell, CEO, Synvivo

PREDiCT Series Attendee

 

A great meeting for networking with industry and academia.

Philip Bernard, Medical Director, University of Utah

PREDiCT Series Attendee

 

This was my first time attending it. I expect to see several interactions and collaborations developing as a result! Great conference! Very good speakers! Organizers did a great job!

Associate Director, The Jackson Laboratory

PREDiCT Series Attendee